Arch Therapeutics Inc (ARTH)

[Regis999]

Biotech Company Review of Total Capital Raised Since Inception to Market Cap

Generally Biotech companies require a lot of cash capital to achieve results. A few require little capital to achieve their desired results.

$ARTH is the best in the biotech universe as far as lowest capital at $24.74 million with a market cap of $ 89.7 million.

For every dollar Arch has raised it has returned $ 3.625561 in market cap. This is extraordinary.



Arch Therapeutics ARTH $ 24.74 M $ 89.70 M 3.625561

When $ARTH is acquired it will be based on the intellectual property that Dr. Norchi has built up.